A Real-World Evaluation of Risk Factors for Disease Progression in Patients With Polycythemia Vera (PV): An Analysis From the Prospective Observational Study of Patients With Polycythemia Vera in US Clinical Practices (REVEAL)

被引：0
|
作者：
Grunwald, Michael R. [1 ]
Zwicker, Jeffrey I. [2 ,3 ]
Gerds, Aaron T. [4 ]
Burke, John M. [5 ]
Xue, Zhenyi [6 ]
Crowgey, Erin L. [6 ]
Carl, Justine [6 ]
Feldman, Patricia [6 ]
Braunstein, Evan M. [6 ]
Oh, Stephen T. [7 ]
机构：
[1] Atrium Hlth, Levine Canc Inst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USA
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[3] Weill Cornell Med Coll, Dept Med, New York, NY USA
[4] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[5] Rocky Mt Canc Ctr, Aurora, CO USA
[6] Incyte Corp, Wilmington, DE USA
[7] Washington Univ, Sch Med, St Louis, MO USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
MPN; polycythemia vera; progression; risk factors;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MPN-120
引用
收藏
页码：S415 / S416
页数：2
相关论文
共 50 条
  • [21] A Real-World Evaluation of the Association between Elevated Blood Counts and Thrombotic Events in Polycythemia Vera (Analysis of Data from the REVEAL Study)
    Gerds, Aaron T.
    Mesa, Ruben A.
    Burke, John M.
    Grunwald, Michael R.
    Stein, Brady Lee
    Scherber, Robyn
    Yu, Jingbo
    Hamer-Maansson, J. E.
    Oh, Stephen
    BLOOD, 2021, 138
  • [22] Risk of Hemorrhage in Patients with Polycythemia Vera Exposed to Aspirin in Combination with Anticoagulants: Results of a Prospective, Multicenter, Observational Cohort Study (REVEAL)
    Zwicker, Jeffrey I.
    Lessen, David S.
    Colucci, Philomena
    Paranagama, Dilan
    Grunwald, Michael R.
    BLOOD, 2019, 134
  • [23] Clinical Outcomes Under Hydroxyurea and Impact of ELN Responses in Patients with Polycythemia Vera: A PV-NET Real World Study
    Palandri, Francesca
    Elli, Elena Maria
    Benevolo, Giulia
    Tiribelli, Mario
    Bonifacio, Massimiliano
    Tieghi, Alessia
    Cavazzini, Francesco
    Palumbo, Giuseppe A.
    Heidel, Florian H.
    Crugnola, Monica
    Binotto, Gianni
    D'Addio, Alessandra
    Polverelli, Nicola
    Bergamaschi, Micaela
    Caocci, Giovanni
    Markovic, Uros
    Auteri, Giuseppe
    Catani, Lucia
    Di Pietro, Christian
    Diral, Elisa
    Scaffidi, Luigi
    Griguolo, Davide
    Codeluppi, Katia
    Cuneo, Antonio
    Semenzato, Gianpietro
    Krampera, Mauro
    Lanza, Francesco
    Lemoli, Roberto Massimo
    Breccia, Massimo
    Bartoletti, Daniela
    Cavo, Michele
    Vianelli, Nicola
    Latagliata, Roberto
    BLOOD, 2019, 134
  • [24] Characteristics, Blood Counts, Treatments, and Clinical Outcomes of 3022 Patients With Polycythemia Vera (PV) Treated in US Community Practices
    Lyons, Roger M.
    Aguilar, Kathleen M.
    Sudharshan, Lavanya
    Venkatasetty, Divea
    Ndukum, Juliet
    Zackon, Ira
    Yu, Jingbo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S325 - S325
  • [25] Impact of Comorbidities and Body Mass Index in Patients with Polycythemia Vera: A PV-NET Real World Study
    Benevolo, Giulia
    Elli, Elena Maria
    Latagliata, Roberto
    Tiribelli, Mario
    Heidel, Florian H.
    Cavazzini, Francesco
    Bonifacio, Massimiliano
    Crugnola, Monica
    Binotto, Gianni
    D'Addio, Alessandra
    Tieghi, Alessia
    Bergamaschi, Micaela
    Caocci, Giovanni
    Polverelli, Nicola
    Diral, Elisa
    Beggiato, Eloise
    Auteri, Giuseppe
    Catani, Lucia
    Sutto, Emanuele
    Griguolo, Davide
    Codeluppi, Katia
    Carmosino, Ida
    Cuneo, Antonio
    Semenzato, Gianpietro
    Krampera, Mauro
    Lanza, Francesco
    Lemoli, Roberto Massimo
    Cavo, Michele
    Bartoletti, Daniela
    Breccia, Massimo
    Palumbo, Giuseppe A.
    Vianelli, Nicola
    Palandri, Francesca
    BLOOD, 2019, 134
  • [26] Characteristics Associated with Hydroxyurea Treatment Change in Patients with Polycythemia Vera: An Analysis from the Reveal Study
    Al-Janadi, Anas
    Mesa, Ruben A.
    Colucci, Philomena
    Parasuraman, Shreekant
    Paranagama, Dilan Chamikara
    Grunwald, Michael Richard
    BLOOD, 2018, 132
  • [27] Real-World Treatments and Thrombotic Events in Polycythemia Vera Patients: A Retrospective Analysis between 2018-2019 in US Population
    Verstovsek, Srdan
    Han, Ariel
    Hayes, Karin Chun
    Woody, Tracy
    Valone, Frank
    Gupta, Suneel K.
    BLOOD, 2020, 136
  • [28] Effect of durable hematocrit control and minimal thrombotic risk in real-world polycythemia vera patients treated with ruxolitinib
    Chojecki, Aleksander Lech
    Boselli, Danielle
    Dortilus, Allison
    Hamadeh, Issam
    Begley, Stephanie
    Chen, Tommy
    Bose, Rupali
    Podoltsev, Nikolai Alexandrovich
    Zeidan, Amer Methqal
    Balmaceda, Nicole Baranda
    Yacoub, Abdulraheem
    Ai, Jing
    Knight, Thomas Gregory
    Ragon, Brittany K.
    Shah, Nilay Arvind
    Sanikommu, Srinivasa
    Symanowski, James Thomas
    Mesa, Ruben A.
    Grunwald, Michael Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] Patterns of hydroxyurea use and clinical outcomes among patients with polycythemia vera in real-world clinical practice: A chart review
    Parasuraman S.
    DiBonaventura M.
    Reith K.
    Naim A.
    Concialdi K.
    Sarlis N.J.
    Experimental Hematology & Oncology, 5 (1)
  • [30] Disease Characteristics of Minority Patient Populations with Polycythemia Vera: An Analysis from the Reveal Study
    Altomare, Ivy
    Colucci, Philomena
    Parasuraman, Shreekant
    Paranagama, Dilan Chamikara
    Al-Janadi, Anas
    BLOOD, 2018, 132
12345